Articles by Patricia Van Arnum - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

KeywordLocation
About Search
Articles by Patricia Van Arnum

Pfizer's R&D facility consolidation

Nov 20, 2009

Following its $68-billion acquisition of Wyeth, Pfizer has unveiled detailed plans for its global R&D network, which includes consolidation of its R&D facilities.

Pfizer Announces R&D Facility Consolidation

Nov 19, 2009

Following the its $68-billion acquisition of Wyeth (Madison, NJ), Pfizer (New York) Pfizer detailed plans for its global research and development (R&D) network, which includes consolidation of its R&D facilities.

Novartis Updates Vaccine Progress in Germany; Acquires Chinese Vaccine Manufacturer

Nov 12, 2009

Novartis reported that German regulatory authorities approved its adjuvanted cell culture-based Influenza A (H1N1) 2009 monovalent vaccine, Celtura. The company also said it will acquire a stake in Chinese vaccines company Zhejiang Tianyuan Bio-Pharmaceutical.

EU Issues Strategy for Influenza A (H1N1) Vaccine Benefit–Risk Monitoring

Nov 12, 2009

The European Medicines Agency, the European Center for Disease Prevention and Control, and the Heads of Medicines Agencies issued a European strategy for H1N1 vaccine benefit–risk monitoring.

CPhI Exhibitors Announce Expansions

Exhibitors announce capacity expansions, service enhancements, and new products at CPhI Worldwide, the large pharmaceutical ingredients and contract services trade show, held in Madrid last month.
Nov 10, 2009

Exhibitors announce capacity expansions, service enhancements, and new products at CPhI Worldwide in Madrid.

Vetter Expands Clinical-and Commercial-Scale Operations

Vetter moves ahead with a new development facility in the US and expanded capabilities in Germany.
Nov 10, 2009

Vetter moves ahead with a new development facility in the US and expanded capabilities in Germany.

Manufacturing and Regulatory Considerations in Biosimilars

Leading experts from an upcoming conference on biosimilars by the Drug, Chemical, and Associated Technologies Association share their insights on the manufacturing and regulatory considerations for biosimilars.
Nov 10, 2009

Leading experts from an upcoming conference on biosimilars by the Drug, Chemical, and Associated Technologies Association share their insights on the manufacturing and regulatory considerations for biosimilars.

SOCMA petition reveals disparity of FDA inspections

Nov 6, 2009

The FDA has responded to a citizen petition from the Society of Chemical Manufacturers and Affiliates (SOCMA) that highlighted the disparity in inspections of domestic and foreign drug-manufacturing facilities.

Lonza plans cost reductions

Nov 6, 2009

Lonza (Switzerland) has announced a series of cost-cutting measures for the next 12¬–18 months.

ADVERTISEMENT

LCGC E-mail Newsletters
Subscribe:Check the box next to each newsletter you wish to subscribe for:
| Weekly
| Monthly
| Monthly | Weekly
 Name:
 E-mail:

Survey
At this month's AAPS Annual Meeting & Exposition, several graduate students were awarded as young innovators. What are your thoughts on innovation and the next generation?
We need more young innovators and more students enrolling in pharma science programs
Our industry has just the right mix of young and old to keep innovation going
Age is irrelevant when it comes to innovation
We need more young innovators and more students enrolling in pharma science programs
26%
Our industry has just the right mix of young and old to keep innovation going
16%
Age is irrelevant when it comes to innovation
58%
View Results
Jim MillerOutsourcing Outlook Jim Miller Facing Reality
Patricia Van ArnumIngredients InsiderPatricia Van Arnum Advancing Chiral Chemistry in API Synthesis
Faiz kermaniSpotlightFaiz Kermani Demographic time bomb
FindPharma Custom Search
Click here